NCT01246375
Unknown
Not Applicable
Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids
ConditionsOsteoporosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Osteoporosis
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Diagnosis of Osteoporosis
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this research is to determine whether the prevalence of osteoporosis is greater in patients who suffer from Chronic obstructive pulmonary disease (COPD) or Asthma disease and uses inhaled steroids.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Man at the minimum age of 60 years.
- •Diagnosed with Chronic Obstructive Pulmonary disease (COPD) or Asthma disease.
- •Usage of the following corticosteroids at the minimal doses indicated, for at least 3 years:
- •Seretide 250/50 mcg Symbicort 320/9 mcg 5.No Diagnosis of thyroid irregularity 6.No diagnosis/treatment for Osteoporosis.
Exclusion Criteria
- •Usage of systemic steroids more than once during the 12 months prior to the study.
- •Usage of systemic steroids during the month prior to the study.
- •Usage of inhaled steroids in order to treat any other disease except Chronic Obstructive Pulmonary Disease (COPD) or Asthma.
Outcomes
Primary Outcomes
Diagnosis of Osteoporosis
Time Frame: 3
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationProstate CancerOsteoporosisNCT00124410AHS Cancer Control Alberta100
Unknown
Phase 3
Prevalence and associated factors of vascular calcification and vascular stiffness in kidney transplant patientsPrevalence and associated factors of osteoporosis, vascular calcification, vascular stiffness in kidney transplant patientsKidney transplantOsteoporosisVascular calcificationVascular stiffnessTCTR20230330007Ratchadapiseksompotch Fund400
Unknown
Not Applicable
Prevalence and associated factors of osteoporosis, vascular calcufication, vascular stiffness in kidney transplant patientsPost kidney transplant more than 1 yearKidney transplantOsteoporosisVascular calcificationVascular stiffnessTCTR20221016002The Kidney Foundation of Thailand400
Recruiting
Not Applicable
Sarcopenia, Fall and Osteoporosis in Chronic Kidney DiseaseSarcopeniaChronic Kidney DiseasesOsteoporosisNCT04515342Herlev Hospital140
Completed
Phase 4
Steroid Induced Osteoporosis in Patients With Systemic Lupus ErythematosusSystemic Lupus ErythematosusNCT00668330Chinese University of Hong Kong40